(CNN) – The vaccine against AstraZeneca’s covid-19 showed 79% of efficacies against surgical devices and 100% of contraindications for serious and serious illnesses in a new clinical setting with a seat in the United States, the company said.
The new Phase 3 hall halls, which included dozens of miles of participants, could generate mayoral confidence in the vacancy, which was originally unveiled by the University of Oxford.
The data will be sent to the Regulatory Officer, the Administration of Medicines and Food (FDA, by its seal in English), as part of an application for emergency authorization of the vaccine in the country, said AstraZeneca.
The test showed that the vaccine was well tolerated and did not identify any security issues, the company said.
An Independent Committee “did not find a mayor risking thrombosis or events characterized by thrombosis among the 21,583 participants who received at least one dose of the vaccine”, according to AstraZeneca.
The new data come from a Phase 3 clinical trial conducted in the United States, Chile and Peru. AstraZeneca says it plans to send the halls a scientific review for its revision in pairs.
The University of Oxford says that the halls are called “the previous dates of the United Kingdom, Brazil and South Africa, as well as the dates of impact in the real world of the United Kingdom”, according to a press release.
As part of the study, more than 32,000 volunteers were recruited every year to receive doses of the vaccine or a placebo at an interval of four weeks.
Controversy over the AstraZeneca store
The Oxford-AstraZeneca vaccine has been the subject of controversy over the principles of my various European countries, including Norway, France and Denmark, and has decided to temporarily suspend its application for information on sanguine coagulation in patients with inoculation.
An Emergency European Medicines Agency (EMA) has launched an investigation into the conclusion, the juvenile passed, that the vaccine is “safe and effective” to prevent coronavirus and “is not associated with an increase in general risk of events thromboembolic or blood clots «.
What do the new dates mean?
The co-designer of the vaccine and professor of vaccinology at the University of Oxford, Sarah Gilbert, praised the data by branding “a mayor’s confirmation of safety and efficacy” of the injection.
The head of the investigating officer of the holiday work and the professor of infection and ammunition of pediatrics and the University of Oxford, Andrew Pollard, is the fact that the AstraZeneca eran is’ consistent with the result of the ensayos dirigidos of Oxford ‘, in addition to hoping for a’ strong impact against covid-19 in all editions and for persons of different origins debited to the generalized use of the window ».